Dipl.-Biol. Ute Steinbusch MBA has been the managing director of Syntab Therapeutics since 2012. She joined the company in 2011. Formerly, she was head of marketing and business development at Celonic GmbH, an SME offering cell culture services. For 4 years, she has been heading the department of cluster development at the regional development agency for the Aachen region, AGIT mbH. In parallel, she studied entrepreneurship at Aachen University of Applied Sciences.
She obtained her diploma in molecular biology at RWTH Aachen University in 2001, in-vitro and in-vivo characterizing a monoclonal antibody applicable in cancer therapy.
Prof. Dr. Christian Becker is co-founder of Syntab and serves as Chief Scientific Officer. In parallel, he has been head of the Institute of Biological Chemistry at University of Vienna since 2011. His major research interests are the controlled modification of peptides and proteins to obtain tailor-made molecules, e.g. modified with polymers, or posttranslational modifications for bio-chemical and biotechnological applications.
Between 2004 and 2008 he worked at the Max-Planck-Institute of Molecular Physiology in Dortmund as a group leader in the department of physical biochemistry. He has two years of experience in the biotech industry working for Gryphon Therapeutics Inc. in South San Francisco, USA, from 2002 to 2003. He obtained his Ph.D. in chemistry from the University of Dortmund in 2001 and his diploma in 1998. Prior to his engagement at the University of Vienna, he was professor and head of the group of protein chemistry at the Technical University Munich since 2008.